Gonorrhoea is caused by Neisseria gonorrhoeae. This is a delicate and fastidious organism which dies rapidly if exposed to desiccating or oxidising conditions and requires a moist carbon dioxide enriched atmosphere and a nutrient medium if it is to be cultured successfully. For these reasons diagnosis by culture was regarded as difficult and uncertain, but many decades ago the problems were overcome, and culture became the method of first choice for diagnosis, and remains the "gold standard" against which others are measured.' However, culture is by no means the only method available for diagnosis of gonorrhoea, and others offer alternative advantages such as speed, robustness, or technical simplicity, and no single method is appropriate in all situations.
In the typical UK microbiology laboratory specimens to be examined for gonococci will usually have been taken from patients in whom there is a significant likelihood of infection, and, on the results obtained, therapy is likely to be administered. Prevalences will vary, but are likely to be highest in patients attending genitourinary medicine clinics and somewhat lower in other patient groups. However, specimens may also be received as part of continuous or intermittent monitoring of particular population groups such as antenatal clinic patients. Here the aim, while including the treatment of any infected patients identified, is primarily to establish background knowledge of the prevalence of infection in that community. Tests employed in these differing situations will need to meet different performance criteria.
Where a clinician is seeking to identify infection in an individual patient the sensitivity of the test (that is, the likelihood of a genuine infection being detected by the test) is of paramount importance, whereas the risk of encountering a false positive result-which relates to the specificity of the test, will be of lesser importance.2 However, in a situation where infection rates are low the problems of encountering false positive results will become more significant, so that the specificity of the test system employed will take on increasing importance and some sensitivity may have to be sacrificed. Moreover, in any situation the likelihood of any test result, either positive or negative, being accurate (the so called positive and negative predictive values) will depend on the number of genuine cases present in the population tested, as well as on the sensitivity and specificity of the test.2 Thus, when numbers are low specificity becomes increasingly important, whereas in a population with a high prevalence of infection, optimal sensitivity should be sought.
Elsewhere in the world the availability of laboratory facilities, and the technical expertise available in these, can be very different from those normally found in the UK, and the prevalence of infection may well be far higher. All these variables will affect the choice of the optimal test to employ-as will financial considerations and the expectations of the population involved. '6 Problems of non-specific inhibition by genital secretions have reduced sensitivity, and specificity problems have also been encountered (see below).
Commercial versions tend to be expensive. All these factors must make them less attractive for population screening in the field or in other situations where difficulties maintaining viability for culture would otherwise exploit their major virtue.
Ribosomal RNA probing The Gen-Probe PACE 2 system (Gen-Probe Inc San Diego, CA, USA)17 uses a magnetic bead separation stage and a chemiluminescent labelled DNA probe to detect gonococcal rRNA. It is very quick but requires expensive kits and equipment. In a high prevalence population sensitivity rates between 100% and 94X2% with specificities between 99-8% and 99.9% for specimens from both sexes and including those from non-genital sites have been reported by authors who felt that the method was more sensitive and more reliable than culture. ' 
CO-AGGLUTINATION
Identification of cultured gonococci by coagglutination of antibody coated staphylococci with easily prepared extracts on a slide is quick, cheap, and very sensitive and specific. It was originally described in 1974.55 A system using polyclonal antibody (Phadebact Gonococcus Test: Pharmacia Diagnostics AB, Uppsala, Sweden) and two systems using different pools of monoclonal antibodies are available (Gono Gen, New Horizons Diagnostic Company, Columbia, MD, USA; and Phadebact GC Omni Test, Pharmacia Diagnostics AB, Uppsala, Sweden). The original monoclonal and the polyclonal systems both gave over 97.5% agreement with neisserial strains in an "in use" test. The monoclonal system retained specificity when challenged with non-gonococcal Neisseria and Branhamella species but the polyclonal antibodies system fared less well. 56 Comparison of the two monoclonal systems57 showed that whereas the GC Omni test gave false positive reactions with N lactamica and N meningitidis which could be overcome by modifying the extraction process, the Gono Gen system gave no false positive reactions but failed to react with occasional gonococci. A recent reassessment54 of the Swedish monoclonal system-as the Phadebact Monoclonal GC test (Boule Diagnostics AB, Huddinge, Sweden) indicated that it retains its ability to detect those gonococci no longer identified by the alternative monoclonal antibodies set when using either fluorescent antibody or coagglutination formats.
The problem of varying responses to serological reagents was In the male the urethra should be sampled. In the female the primary site of infection is the cervix, but the urethra is frequently infected also and should also be sampled, thus 85 Culture of urine in women has proved less successful. Thus, Chapel and Smeltzer86 were only able to grow gonococci from the centrifuged deposit of 72-3% of female cases of gonorrhoea, but as the site of primary infection in women is the cervix (see above) this is unsurprising.
Molecular techniques have also been employed successfully on these specimens. Thus the Gen-Probe PACE 2 yielded 98.3% sensitivity and 96.4% specificity with symptomatic male urine.87 By combining this with a similar test for Chlamydia trachomatis a noninvasive socially acceptable sensitive and transportable system is available for the diagnosis or screening for two sexually transmitted diseases of major importance. In women also the great sensitivity of these tests has proved of value. Thus the ligase chain reaction technique has been shown to be 94.7 and 94.6% sensitive and 100% specific when testing first voided urine samples from STD clinics. '5 88 Biological variability In the animal kingdom the reproductive process is sexual and involves a reassortment of genes at each generation. Thus each indi-vidual is genetically unique. However, in the bacterial kingdom reproduction is a vegetative process with no stage of recombination. Such genetic alteration as does occur takes place by mutation in individual cells or by transfer of genetic material between cells by conjugation or by transformation. These are usually uncommon events and many bacterial species are highly clonal, being stable in character for many years and showing little variation throughout the world. 89 Gonococci, in contrast, are uniquely competent to exchange DNA by transformation and in consequence are highly variable and non-clonal. 90 Thus their characteristics alter and it is to be expected that no test seeking a relatively small number of identifying enzymes or antigenic markers will ever detect all gonococci, and strains will be encountered that show features of gonococci and also of other Neisseriae. One such example is N gonorrhoeae sub sp kochii, which has certain characteristics of the meningococcus and is often encountered in Egypt.91 Others are only met rarely92 but all series of cultures will include biochemically aberrant strains. Thus final identification must be based on an Adansonian concept and, in practice, judgment will always be necessary as the final arbiter. Knapp93 recommends that important or difficult decisions should be based on tests relying on more than one diagnostic principle, but opines that a very small minority of isolates will never be satisfactorily speciated.
Conclusion
A very wide range of test procedures are currently available for the diagnosis of gonorrhoea. Choice of a particular system will be based on the weighing of the relative advantages and disadvantages of all those available, and significantly different decisions may be reached, entirely correctly, in the myriad differing circumstances which will be encountered in the UK and elsewhere in the world.
